Trending

Views & Analysis

J&J tops the pharma market cap charts – but for how long?

J&J tops the pharma market cap charts – but for how long?

Data and analytics firm GlobalData has tracked the market cap and performance of the top 25 pharma companies

X

J&J tops the pharma market cap charts – but for how long?

https://pharmaphorum.com/views-and-analysis/jj-tops-pharma-market-cap-charts-long/

Was pharma bold enough at Lions Health 2018?

Was pharma bold enough at Lions Health 2018?

The Lions Health 2018 jury brought 10 senior communications executives together in Cannes, with representatives from China, Australia,

X

Was pharma bold enough at Lions Health 2018?

https://pharmaphorum.com/views-analysis-sales-marketing/pharma-bold-cannes-lions-health-2018/

How to achieve digital success in pharma’s communications

How to achieve digital success in pharma’s communications

Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for

X

How to achieve digital success in pharma’s communications

https://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/

Future-proofing pharma with a multichannel approach to sales and marketing

Future-proofing pharma with a multichannel approach to sales and marketing

Deploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and

X

Future-proofing pharma with a multichannel approach to sales and marketing

https://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/

How the EU’s GDPR will be a positive catalyst for change

How the EU’s GDPR will be a positive catalyst for change

Now that the GDPR deadline of May 25 has come and gone, many life sciences companies will have

X

How the EU’s GDPR will be a positive catalyst for change

https://pharmaphorum.com/views-analysis-digital/gdpr/

The user experience in your clinical trials: it really matters

The user experience in your clinical trials: it really matters

Everybody knows the current clinical trial model is broken. But it’s not technology that will fix it –

X

The user experience in your clinical trials: it really matters

https://pharmaphorum.com/r-d/views-analysis-r-d/the-user-experience-in-your-clinical-trials-it-really-matters/

How Merck is stepping up for patients

How Merck is stepping up for patients

Patient centricity is a priority for Merck and its Executive Vice President and Head of EMEA Region, Chris Round, outlines what practical steps the company is taking to improve life for patients and carers.

X

How Merck is stepping up for patients

https://pharmaphorum.com/views-analysis-patients/how-merck-is-stepping-up-for-patients/

Can ‘design thinking’ revolutionise pharma’s culture?

Can ‘design thinking’ revolutionise pharma’s culture?

As part of pharmaphorum’s ‘eye-on-innovation’ series, Paul Tunnah speaks to UCB’s head of innovation, Gregory Miller, about how

X

Can ‘design thinking’ revolutionise pharma’s culture?

https://pharmaphorum.com/views-and-analysis/can-design-thinking-revolutionise-pharmas-culture/

Pharma must live and breathe patient centricity

Pharma must live and breathe patient centricity

Patient-centric programmes that ignore the ‘BREATHE’ principles will fail to hit the mark and leave patients behind, according

X

Pharma must live and breathe patient centricity

https://pharmaphorum.com/views-analysis-patients/pharma-must-live-and-breathe-patient-centricity/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com